Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells
- PMID: 16906167
- DOI: 10.1038/ni1375
Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells
Abstract
Interleukin 27 (IL-27) was first characterized as a proinflammatory cytokine with T helper type 1-inducing activity. However, subsequent work has demonstrated that mice deficient in IL-27 receptor (IL-27R alpha) show exacerbated inflammatory responses to a variety of challenges, suggesting that IL-27 has important immunoregulatory functions in vivo. Here we demonstrate that IL-27R alpha-deficient mice were hypersusceptible to experimental autoimmune encephalomyelitis and generated more IL-17-producing T helper cells. IL-27 acted directly on effector T cells to suppress the development of IL-17-producing T helper cells mediated by IL-6 and transforming growth factor-beta. This suppressive activity was dependent on the transcription factor STAT1 and was independent of interferon-gamma. Finally, IL-27 suppressed IL-6-mediated T cell proliferation. These data provide a mechanistic explanation for the IL-27-mediated immune suppression noted in several in vivo models of inflammation.
Comment in
-
All in the family: IL-27 suppression of T(H)-17 cells.Nat Immunol. 2006 Sep;7(9):899-901. doi: 10.1038/ni0906-899. Nat Immunol. 2006. PMID: 16924249 No abstract available.
Similar articles
-
A Th17-like developmental process leads to CD8(+) Tc17 cells with reduced cytotoxic activity.Eur J Immunol. 2009 Jul;39(7):1716-25. doi: 10.1002/eji.200939412. Eur J Immunol. 2009. PMID: 19544308
-
Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity.Immunity. 2009 Aug 21;31(2):331-41. doi: 10.1016/j.immuni.2009.08.001. Epub 2009 Aug 13. Immunity. 2009. PMID: 19682929
-
IL-21 and IL-21R are not required for development of Th17 cells and autoimmunity in vivo.Eur J Immunol. 2008 Jul;38(7):1833-8. doi: 10.1002/eji.200838511. Eur J Immunol. 2008. PMID: 18546146
-
Pathophysiology of interleukin-23 in experimental autoimmune encephalomyelitis.Drug News Perspect. 2006 Mar;19(2):77-83. doi: 10.1358/dnp.2006.19.2.977443. Drug News Perspect. 2006. PMID: 16628262 Review.
-
Targeting the development and effector functions of TH17 cells.Semin Immunol. 2007 Dec;19(6):383-93. doi: 10.1016/j.smim.2007.10.016. Epub 2008 Jan 14. Semin Immunol. 2007. PMID: 18083530 Review.
Cited by
-
IL-27 Regulates IL-18 binding protein in skin resident cells.PLoS One. 2012;7(6):e38751. doi: 10.1371/journal.pone.0038751. Epub 2012 Jun 27. PLoS One. 2012. PMID: 22761702 Free PMC article.
-
Inborn errors of human IL-17 immunity underlie chronic mucocutaneous candidiasis.Curr Opin Allergy Clin Immunol. 2012 Dec;12(6):616-22. doi: 10.1097/ACI.0b013e328358cc0b. Curr Opin Allergy Clin Immunol. 2012. PMID: 23026768 Free PMC article. Review.
-
Modulation of inflammation by interleukin-27.J Leukoc Biol. 2013 Dec;94(6):1159-65. doi: 10.1189/jlb.0213107. Epub 2013 Jul 31. J Leukoc Biol. 2013. PMID: 23904441 Free PMC article. Review.
-
Interleukin-27 receptor limits atherosclerosis in Ldlr-/- mice.Circ Res. 2012 Oct 26;111(10):1274-85. doi: 10.1161/CIRCRESAHA.112.277525. Epub 2012 Aug 27. Circ Res. 2012. PMID: 22927332 Free PMC article.
-
Regulation of defense responses against protozoan infection by interleukin-27 and related cytokines.J Biomed Biotechnol. 2007;2007(3):79401. doi: 10.1155/2007/79401. Epub 2007 Apr 23. J Biomed Biotechnol. 2007. PMID: 17541470 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous